Skip to main content

and
  1. No Access

    Article

    Deciphering the effects of graft Tregs on chronic graft-versus-host disease: results from a prospective, multicenter study in patients with acute leukemia undergoing allogeneic peripheral blood stem cell transplantation

    Mario Delia, Paola Carluccio, Vito Pier Gagliardi in Bone Marrow Transplantation (2022)

  2. Article

    Open Access

    Myeloablative conditioning with thiotepa-busulfan-fludarabine does not improve the outcome of patients transplanted with active leukemia: final results of the GITMO prospective trial GANDALF-01

    The outcome of refractory/relapsed (R/R) acute leukemias is still dismal and their treatment represents an unmet clinical need. However, allogeneic transplantation (allo-HSCT) remains the only potentially cura...

    Francesca Bonifazi, Chiara Pavoni, Jacopo Peccatori in Bone Marrow Transplantation (2022)

  3. No Access

    Article

    The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study

    The experience of third-generation tyrosine kinase inhibitor ponatinib treatment in Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph’+ ALL) patients post-allogeneic transplantation is limited...

    Salvatore Leotta, Uros Markovic, Maria Cristina Pirosa in Annals of Hematology (2021)

  4. No Access

    Article

    Antiemetic prophylaxis in patients undergoing hematopoietic stem cell transplantation: a multicenter survey of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) transplant programs

    A survey within hematopoietic stem cell transplant (HSCT) centers of the Gruppo Italiano Trapianto Midollo Osseo (GITMO) was performed in order to describe current antiemetic prophylaxis in patients undergoing...

    Domenico Pastore, Benedetto Bruno, Paola Carluccio in Annals of Hematology (2020)

  5. No Access

    Article

    Health-related quality of life, symptom burden, and comorbidity in long-term survivors of acute promyelocytic leukemia

    The objective of this study was to investigate health-related quality of life (HRQOL), symptom burden, and comorbidity profile in long-term acute promyelocytic leukemia (APL) survivors treated with standard ch...

    Fabio Efficace, Massimo Breccia, Giuseppe Avvisati, Francesco Cottone in Leukemia (2019)

  6. No Access

    Article

    Vascular density and inflammatory infiltrate in primary oral squamous cell carcinoma and after allogeneic hematopoietic stem cell transplantation

    Hematopoietic stem cell transplantation (HSCT) recipients have been reported to have an increased risk of chronic graft versus host disease (cGVHD) and hematological and solid cancers. Oral manifestations are ...

    Roberto Tamma, Luisa Limongelli, Eugenio Maiorano, Domenico Pastore in Annals of Hematology (2019)

  7. Article

    Open Access

    Droplet digital PCR for the quantification of Alu methylation status in hematological malignancies

    Alu repeats, belonging to the Short Interspersed Repetitive Elements (SINEs) class, contain about 25% of CpG sites in the human genome. Alu sequences lie in gene-rich regions, so their methylation is an import...

    Paola Orsini, Luciana Impera, Elisa Parciante, Cosimo Cumbo in Diagnostic Pathology (2018)

  8. Article

    Open Access

    ADAMTS2 gene dysregulation in T/myeloid mixed phenotype acute leukemia

    Mixed phenotype acute leukemias (MPAL) include acute leukemias with blasts that express antigens of more than one lineage, with no clear evidence of myeloid or lymphoid lineage differentiation. T/myeloid (T/My...

    Giuseppina Tota, Nicoletta Coccaro, Antonella Zagaria, Luisa Anelli in BMC Cancer (2014)

  9. No Access

    Article

    Use of tyrosine kinase inhibitors in a patient with Brugada syndrome and chronic myeloid leukemia

    The treatment and prognosis of chronic myeloid leukemia have dramatically changed since the introduction of tyrosine kinase inhibitors, but although several clinical trials have examined their safety with resp...

    Nicola Sgherza, Antonella Vita Russo Rossi in International Journal of Hematology (2013)